A549 cells infected with IAV Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RUNX2 | hg19_v2_chr6_+_45296048_45296106 | -0.99 | 5.7e-03 | Click! |
RUNX1 | hg19_v2_chr21_-_36421401_36421462 | -0.98 | 2.4e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_+_73780852 Show fit | 0.61 |
ENST00000589666.1
|
unkempt family zinc finger |
|
chr17_+_75316336 Show fit | 0.54 |
ENST00000591934.1
|
septin 9 |
|
chr14_-_81425828 Show fit | 0.47 |
ENST00000555529.1
ENST00000556042.1 ENST00000556981.1 |
centrosomal protein 128kDa |
|
chr19_+_54495542 Show fit | 0.46 |
ENST00000252729.2
ENST00000352529.1 |
calcium channel, voltage-dependent, gamma subunit 6 |
|
chr6_+_24126350 Show fit | 0.42 |
ENST00000378491.4
ENST00000378478.1 ENST00000378477.2 |
neurensin 1 |
|
chr19_-_55895966 Show fit | 0.41 |
ENST00000444469.3
|
transmembrane protein 238 |
|
chr11_+_2923423 Show fit | 0.38 |
ENST00000312221.5
|
solute carrier family 22, member 18 |
|
chr1_+_179051160 Show fit | 0.37 |
ENST00000367625.4
ENST00000352445.6 |
torsin family 3, member A |
|
chr5_-_108063949 Show fit | 0.37 |
ENST00000606054.1
|
long intergenic non-protein coding RNA 1023 |
|
chr11_+_2923499 Show fit | 0.36 |
ENST00000449793.2
|
solute carrier family 22, member 18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.8 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.7 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.1 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.1 | 0.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.0 | 0.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.5 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.4 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.8 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.6 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.0 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.9 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |